STERIS plc
NYSE:STE
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
197.44
247.17
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
STERIS plc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | IE |
Market Cap | 21.3B USD |
Net Margin |
8%
|
Country | US |
Market Cap | 205.2B USD |
Net Margin |
14%
|
Country | US |
Market Cap | 193.1B USD |
Net Margin |
29%
|
Country | US |
Market Cap | 148.6B USD |
Net Margin |
16%
|
Country | US |
Market Cap | 132.9B USD |
Net Margin |
11%
|
Country | IE |
Market Cap | 109.9B USD |
Net Margin |
13%
|
Country | US |
Market Cap | 64.8B USD |
Net Margin |
9%
|
Country | DE |
Market Cap | 56.7B EUR |
Net Margin |
8%
|
Country | CN |
Market Cap | 325.5B CNY |
Net Margin |
33%
|
Country | US |
Market Cap | 42.2B USD |
Net Margin |
74%
|
Country | US |
Market Cap | 37.7B USD |
Net Margin |
9%
|
STERIS plc
Glance View
STERRIS plc is a globally recognized leader in the field of infection prevention, surgical, and critical care solutions, committed to enhancing patient safety and healthcare efficiency. With a rich history spanning over 100 years, the company operates in more than 60 countries, offering a diverse range of products and services tailored to meet the needs of healthcare providers. STERIS’s innovative technologies, including sterilization and disinfection equipment, surgical tables, and integrated surgical suites, position it as a vital partner for hospitals and medical facilities striving to uphold high standards of patient care. This focus on innovation not only drives customer loyalty but also positions the company favorably in an industry that increasingly prioritizes safety and efficiency. For investors, STERIS presents a robust growth trajectory, bolstered by a strategic approach to acquisitions and an expansion into emerging markets. The company has consistently delivered strong financial results, reflecting resilience even amidst industry challenges. With an ongoing commitment to research and development, STERIS is well-positioned to leverage trends in healthcare modernization and increasing demand for infection control solutions. As global healthcare systems adapt to rising patient care standards and regulatory requirements, STERIS’s established reputation and forward-thinking strategies make it an attractive investment opportunity for those looking to capitalize on the evolving landscape of healthcare services.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on STERIS plc's most recent financial statements, the company has Net Margin of 8.5%.